Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Saved in:
| Title: | Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). |
|---|---|
| Authors: | Mohty R; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Narra R; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Mims AS; Division of Hematology and Oncology, Ohio State University, Columbus, OH, USA., Hunter C; Division of Hematology and Oncology, Yale University, New Haven, CT, USA., Shallis RM; Division of Hematology and Oncology, Yale University, New Haven, CT, USA., Kota V; Division of Hematology and Oncology, Georgia Cancer Center, Augusta, GA, USA., Jamy O; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Coltoff A; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC, USA., Othman TA; Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California, Davis, CA, USA., Jonas BA; Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California, Davis, CA, USA., Patel AA; Division of Hematology and Oncology, University of Chicago, Chicago, IL, USA., DuVall AS; Division of Hematology and Oncology, University of Chicago, Chicago, IL, USA., Foucar CE; Division of Hematology and Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Abdelsamia M; Division of Hematology and Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Palmisiano N; Division of Hematology and Oncology, Jefferson University Hospital, Philadelphia, PA, USA., Patel SA; Department of Medicine-Division of Hematology/Oncology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, MA, USA., Curran E; Division of Hematology and Oncology, University of Cincinnati, Cincinnati, OH, USA., Omer Z; Division of Hematology and Oncology, University of Cincinnati, Cincinnati, OH, USA., Advani A; Division of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Atallah E; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Litzow MR; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Badar T; Division of Hematology-Oncology and Bone Marrow Transplant Program, Mayo Clinic, Jacksonville, FL, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Jun; Vol. 67 (7), pp. 1587-1594. Date of Electronic Publication: 2026 Apr 09. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2026.2650679 |
